MUSCELLA, Antonella
 Distribuzione geografica
Continente #
EU - Europa 10.962
NA - Nord America 10.341
AS - Asia 7.748
SA - Sud America 1.321
Continente sconosciuto - Info sul continente non disponibili 404
AF - Africa 205
OC - Oceania 11
AN - Antartide 1
Totale 30.993
Nazione #
US - Stati Uniti d'America 9.782
IT - Italia 3.545
SG - Singapore 3.457
IE - Irlanda 2.533
RU - Federazione Russa 2.111
CN - Cina 1.416
HK - Hong Kong 1.120
BR - Brasile 1.082
VN - Vietnam 671
SE - Svezia 667
UA - Ucraina 529
DE - Germania 450
IN - India 343
CA - Canada 285
FR - Francia 267
FI - Finlandia 260
GB - Regno Unito 234
KR - Corea 148
BD - Bangladesh 133
MX - Messico 96
AR - Argentina 92
JP - Giappone 88
ZA - Sudafrica 70
PL - Polonia 64
IQ - Iraq 61
PK - Pakistan 52
ES - Italia 46
EC - Ecuador 45
NL - Olanda 43
SN - Senegal 43
TR - Turchia 42
ID - Indonesia 41
BE - Belgio 39
LT - Lituania 33
CZ - Repubblica Ceca 30
IR - Iran 29
SV - El Salvador 27
CR - Costa Rica 26
AT - Austria 22
GP - Guadalupe 21
VE - Venezuela 21
AE - Emirati Arabi Uniti 20
CO - Colombia 20
GT - Guatemala 20
JM - Giamaica 20
CW - ???statistics.table.value.countryCode.CW??? 19
TN - Tunisia 18
CL - Cile 17
IL - Israele 16
MA - Marocco 16
UZ - Uzbekistan 16
EG - Egitto 14
PY - Paraguay 14
MY - Malesia 13
PE - Perù 13
PR - Porto Rico 13
SA - Arabia Saudita 12
HN - Honduras 11
NI - Nicaragua 11
NP - Nepal 11
TT - Trinidad e Tobago 11
BG - Bulgaria 10
RO - Romania 10
CH - Svizzera 9
DZ - Algeria 9
HU - Ungheria 9
AU - Australia 8
EE - Estonia 8
KE - Kenya 8
SC - Seychelles 8
UY - Uruguay 8
BO - Bolivia 7
ET - Etiopia 7
JO - Giordania 7
AL - Albania 5
AZ - Azerbaigian 5
EU - Europa 5
LB - Libano 5
PH - Filippine 5
PS - Palestinian Territory 5
PT - Portogallo 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
GR - Grecia 4
MD - Moldavia 4
TW - Taiwan 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
BZ - Belize 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
KZ - Kazakistan 3
SI - Slovenia 3
AO - Angola 2
BW - Botswana 2
CG - Congo 2
Totale 30.574
Città #
Dublin 2.527
Lecce 2.466
Singapore 1.241
Ashburn 1.135
San Jose 1.079
Hong Kong 1.044
Council Bluffs 929
Moscow 652
Chandler 511
Dallas 499
Beijing 370
New York 317
Jacksonville 289
Santa Clara 261
Ho Chi Minh City 240
Los Angeles 212
Wayanad 189
Milan 174
Princeton 172
Lauterbourg 168
Hanoi 164
Munich 157
Seoul 142
São Paulo 127
Des Moines 99
Frankfurt am Main 99
Orem 87
Phoenix 82
Tokyo 82
Brooklyn 80
Helsinki 79
Montreal 77
Rome 72
Bari 68
Atlanta 65
Wilmington 59
Chicago 58
Chennai 57
Denver 56
London 55
Seattle 55
West Jordan 55
Ogden 54
Ann Arbor 50
Central District 50
Warsaw 50
North Bergen 48
Mexico City 47
Toronto 45
Lequile 44
Dakar 43
Johannesburg 42
Stockholm 42
Poplar 41
Rio de Janeiro 41
Houston 39
Boston 38
Miano 38
Naples 38
Brussels 36
Da Nang 35
Seelze 34
Detroit 32
Bakersfield 31
Haiphong 30
San Francisco 30
Miami 28
Copertino 27
Kent 27
Manchester 27
San Pietro Vernotico 26
Baghdad 25
Columbus 25
Falkenstein 25
Turku 25
The Dalles 24
Jinan 23
Nuremberg 23
San Salvador 23
Ankara 22
Brasília 22
Guangzhou 22
Lappeenranta 22
Boardman 21
Brno 21
Falls Church 21
Amsterdam 19
Bologna 19
Mumbai 19
San José 19
St Louis 19
Willemstad 19
Augusta 18
San Mateo 18
Bremen 17
Tianjin 17
Kingston 16
Lahore 16
Querétaro 16
Turin 16
Totale 18.055
Nome #
Exchequer motor game enhances geometric thinking and mood in first grade children 270
Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines 269
A monoclonal antibody to mammalian Angiotensin II AT1 receptor recognises one of the Angiotensin II receptor isoforms expressed by the eels. 265
INJURY PREVENTION IN YOUNG SOCCER PLAYERS: RESULTS OF A PILOT STUDY 263
[Pt(O,O'-acac)(γ-acac)(DMS)] induces autophagy and apoptosis in Skov-3 ovarian carcinoma cells 259
[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 257
ADP sensitizes ZL55 cells to the activity of cisplatin 255
Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway 252
A new platinum(II) complex with high cytotoxicity in human endometrial cancer HeLa cells. 251
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits malignant pleural mesothelioma cells in vitro and in vivo 249
Referees' physical performance over a soccer season 245
[Pt(O,O'-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells 243
A new platinum (II) complex exerts higher cytotoxicity in tumoral than in normal human breast cells in primary culture. 242
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells. 241
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma 237
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells 236
A new platinum(II) complex with high cytotoxicity in normal and tumoural thyroid cell lines 235
[Pt(O,O'-acac)(gamma-acac)(DMS)] alters the expression of genes for cell cycle regulation and invasive function 234
[Pt(O,O’-acac)(γ-acac)(DMS)] affects the intracellular Ca2+ homeostasis in MCF-7 breast cancer cells 233
ADP sensitizes ZL55 cells to the activity of anticancer cisplatin 233
[Pt(O,O’-acac)(γ-acac)(DMS)] exerts high and fast cytotoxicity in breast cancer cells in primary culture 231
Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells 230
[Pt(O,O’-acac)(γ-acac)(DMS)]: in vivo Studies of a Promising Anticancer Drug in Cancer Therapy 227
Antitumor and Antiangiogenic Activities of [Pt(O,O' acac)(γ-acac)(DMS)] in human renal cell carcinoma 225
[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway. 222
In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma 222
[Pt(O,O’-acac)(γ-acac)(DMS)]: a comparative study with cisplatin in vivo. 222
1H-NMR metabolomic study of SKOV-3 cells, response to the [Pt(O,O′-acac)(γ-acac)(DMS)] treatment 221
Antitumor and antimigration effects of a new Pt compound on neuroblastoma cells 220
PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin 219
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects 217
Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+ATPase in HeLa cells 213
Cytotoxicity of new organometallic Pt(II)-complexes containing 1,10-phenantroline 212
Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells 209
Antitumor activity of [Pt(O,O’-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer 208
Response of cisplatin resistant SkOV-3 cells to [PT(O,O'-Acac)(γ-Acac)(DMS)] Treatment revealed by a metabolomic 1H-NMR study 208
The effects of exercise training on lipid metabolism and coronary heart disease 208
[Pt(O,O’-acac)(γ-acac)(DMS)] inhibits adhesion and migration of breast cancer cells 207
The effects of training on hormonal concentrations in young soccer players 205
Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture. 204
Cisplatin-analogous β-diketonate Pt(II) organometallic species: reactivity and cytotoxicity 200
Activation of P2Y2 receptor induces C-Fos protein through a pathway Involving Mitogen-Activated Protein Kinase and phosphoinositide 3-kinases in HeLa cells. 199
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits migration of tumor human breast cells in primary cultures 198
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells 197
Transbulbar B-Mode Sonography in Multiple Sclerosis: Clinical and Biological Relevance 197
Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study 197
Angiotensin II stimulates the Na+/H+ exchanger in human umbilical vein endothelial cells via AT1 receptor 196
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells 193
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells. 193
[Pt(O,O’-acac)(γ-acac)(DMS)] induces apoptosis in human breast cancer cells in primary culture 192
Is mitochondrial DNA profiling predictive for athletic performance? 191
Cisplatin activates the PKC/ERK1/2 intracellular transduction pathways in rat thyroid PC Cl3 cells 188
Angiotensin II stimulation of the basolateral located Na/H antiporter in eel (Anguilla anguilla) enterocytes 186
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 186
Cytotoxicity of [Pt(O,O’-acac)(γ-acac)(DMS)] in normal and cancerous human breast cells in primary culture 183
Dopamine and antioxidant grape seed extract loaded chitosan nanoparticles: A preliminary in vitro characterization. 181
Bradykinin stimulates prostaglandin E2 release in human skeletal muscular fibroblasts 181
Immunolocalization of the AT-1R Ang II Receptor in Human Kidney Cancer 180
NMR-based metabolomic analyses of cisplatin resistant SKOV-3 cell line response to [Pt (O,O′-acac)(γ-acac)(DMS)], Ptac2S, treatment: comparison to cisplatin 179
Synthesis and comparative evaluation of the cytotoxic activity of cationic organometallic complexes of the type [Pt(η1-CH2-CH2-OR)(DMSO)(phen)]+ (R = Me, Et, Pr, Bu) 176
Different regulation of matrix metalloproteinase-2 in cisplatin response of normal and transformed thyroid cells 176
The Angiosuppressive Effects of [Pt(O,O′-acac)(γ-acac)(DMS)] 176
Multiple isoforms of the oestrogen receptor in endometrial cancer 174
Protein kinase C-delta mediates cisplatin-induced apoptosis of ZL55 mesothelioma cells 174
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells 174
Immunolocalisation of angiotensin II receptors in icefish (Chionodraco hamatus) tissues. 173
Synthesis and characterization of new water-soluble organometallic complexes of the type [PtL(h1-C2H4OMe)(N^N)] (L = NH3, DMSO; N^N = dinitrogen ligand) with potential antitumor activity 172
NEW B-DIKETONATE PT(II) ORGANOMETALLIC SPECIES EXHIBITING HIGHER CYTOTOXIC ACTIVITY ON CANCER CELLS THAN CISPLATIN. 171
Cytotoxic Activity of New β-Diketonate Platinum(II) Complexes on Cancer Cells 171
A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells 171
AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma 170
PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells 170
A novel monoclonal antibody to a plasmamembrane-located breast cancer antigen Interferes with the proliferation rate of cancerous cells in vitro 169
CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture 169
Mitochondria-mediated apoptosis by a new Pt(II) compound, [Pt(O,O’-acac)(g-acac) (DMS)], in human breast cancer cells 168
Angiotensin II AT1 Receptor Stimulates Na+/K+ATPase Activity Through a Pathway Involving PKC-z in Rat Thyroid Cells. 168
Increase of [Ca2+]i via activation of ATP receptors in PC-Cl3 rat thyroid cell line 166
Purinergic receptors in a pleural mesotelioma cell line. 166
Effect of tumour size on the association between pS2 and cathepsin D in primary breast cancer 165
Involvement of Protein Kinase Cdelta and -epsilon in cisplatin-induced apoptosis in thyroid cells. 164
Angiotensin II modulates the activity of Na+/K+ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation 162
Synthesis, characterization and cytotoxic activity of novel Pt(II) complexes with acetylacetonate and amines 161
Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. 160
Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma Cells 159
EGFR MEDIATES THE CYTOTOXICITY OF CISPLATIN IN THE DIFFERENTIATED RAT THYROID PC CL3 CELL LINE THROUGH THE ACTIVATION OF MAPK/P38 159
Monitoring Psychometric States of Recovery to Improve Performance in Soccer Players: A Brief Review 158
Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell Lines 156
Differential activation of ERK1/2 in human breast cancer MCF-7 cells treated with cisplatin or [Pt(O,O’-acac)(γ-acac)(DMS)] 156
CCL20 induces migration and proliferation on breast epithelial cells 155
Transforming growth factor-β1 induces matrix metalloproteinase and cell migration in Schwann cells. 155
In vivo study on xenograft model: [Pt(O,O’-acac)(γ-acac)(DMS)] versus cisplatin 155
ERK activation in cisplatin response in thyroid cell lines 154
PKC-epsilon-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC Cl3 cells. 153
Efficacy of school-based intervention programs in reducing overweight: A randomized trial 152
Molecular Studies on Cisplatin Analogues 152
The effects of training on hormonal concentrations and physical performance of football referees 152
Angiotensin II receptors in the gill of sea water- and freshwater-adapted eel 151
Effects of extracellular nucleotides in the thyroid: P2Y(2) receptor-mediated ERK1/2 activation and c-Fos induction in PC Cl3 cells 151
Cytotoxic activity in vitro of cisplatin and its analogous [Pt(acac)Cl(DMSO)]. 151
Involvement of Protein Kinase C-delta and -epsylon in cisplatin-induced apoptosis in thyroid cells 151
Totale 19.602
Categoria #
all - tutte 139.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 0 78 109 12 22 49 21 64 118 257
2022/20234.325 192 334 173 132 156 268 29 189 2.681 14 98 59
2023/20241.581 132 91 107 92 133 158 22 58 221 307 173 87
2024/20255.122 98 29 109 80 342 558 180 249 1.679 538 477 783
2025/202611.849 1.086 1.413 1.024 1.550 1.243 570 1.365 534 1.615 811 438 200
2026/20273.587 306 769 561 1.951 0 0 0 0 0 0 0 0
Totale 30.993